The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 13 October 2003 doi:10.1084/jem.20030471
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 372K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blaeser, F.
Right arrow Articles by Chatila, T. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blaeser, F.
Right arrow Articles by Chatila, T. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© Rockefeller University Press, 0022-1007/2003/10/1189 $5.00
The Journal of Experimental Medicine, Volume 198, Number 8, 1189-1200

Targeted Inactivation of the IL-4 Receptor {alpha} Chain I4R Motif Promotes Allergic Airway Inflammation

Frank Blaeser1, Paul J. Bryce2, Nga Ho1, Vidya Raman1, Fatma Dedeoglu2, Debra D. Donaldson3, Raif S. Geha2, Hans C. Oettgen2 and Talal A. Chatila1,4

1 Department of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110
2 Department of Pediatrics, Harvard Medical School, Boston, MA 02115
3 Department of Respiratory Disease, Wyeth Research, Cambridge, MA 02140
4 Department of Pathology and Immunology and the Center for Immunology, Washington University School of Medicine, St. Louis, MO 63110

Address correspondence to Talal A. Chatila, Dept. of Pediatrics, The David Geffen School of Medicine, University of California at Los Angeles, 10833 Le Conte Ave., Los Angeles, CA 90095-1752. Phone: (310) 825-4125; Fax: (310) 206-4584; email: Tchatila{at}mednet.ucla.edu

The insulin/interleukin-4 (IL-4) receptor (I4R) motif mediates the association of insulin receptor substrate (IRS)-2 with the interleukin-4 (IL-4)R{alpha} chain and transduces mitogenic signals in response to IL-4. Its physiological functions were analyzed in mice with a germline point mutation that changed the motif's effector tyrosine residue into phenylalanine (Y500F). The Y500F mutation abrogated IRS-2 phosphorylation and impaired IL-4–induced CD4+ T lymphocyte proliferation but left unperturbed Stat6 activation, up-regulation of IL-4-responsive gene products, and Th cell differentiation under Th2 polarizing conditions. However, in vivo the Y500F mutation was associated with increased allergen-induced IgE production, airway responsiveness, tissue eosinophilia, and mucus production. These results define an important role for the I4R motif in regulating allergic inflammation.

Key Words: interleukin 4 receptor • targeted mutagenesis • immunoglobulin E • insulin receptor substrate • asthma


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS